📰 Boxed Warning News
Page 39 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
October 13, 2022
/PRNewswire/ -- Neurelis, Inc., today announced findings from a novel, investigational analysis of the time between seizure clusters in pediatric patients...
September 30, 2022
Ironshore Announces Executive Appointments and Strengthening of the Global Business Management Team - read this article along with other careers information, tips and advice on BioSpace
September 30, 2022
The FDA has approved Besremi (ropeginterferon alfa-2b-njft), an interferon alfa-2b, for the treatment of adults with polycythemia vera.
September 27, 2022
Posimir (bupivacaine solution) is now available for postsurgical analgesia for up to 72 hours following arthroscopic subacromial decompression.
September 27, 2022
NEW YORK - Y-mAbs Therapeutics, Inc. , a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of... | September 27, 2022
September 26, 2022
/PRNewswire/ -- Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, and DURECT...
September 26, 2022
Y-mAbs Therapeutics, Inc. (“Y-mAbs”, NASDAQ: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel,
September 22, 2022
The FDA has approved 2 new macrocyclic gadolinium-based contrast agents, Elucirem (gadopiclenol) and Vueway (gadopiclenol).
September 21, 2022
RALEIGH, N.C., Sept. 21, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 2, 2022 by Marius Pharmaceuticals, please note...
September 20, 2022
? Clinical, Epidemiology and Health Economics and Outcomes Research Shared at Key Psychiatry Conference ? DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced